| Financial Year |
March 31 2022 |
| Monetary Funds |
478,880,465.72 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
3,826,885.00 |
| Accounts Receivable |
16,030,291.33 |
| Advances to Suppliers |
11,860,746.56 |
| Other Receivables |
29,238,370.83 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
40,903,067.84 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,094,717.53 |
| Total Current Assets |
586,834,544.81 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
2,880,867.35 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,833,700.26 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
2,305,444.21 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
10,171,552.61 |
| Total Assets |
597,006,097.42 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,658,480.48 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
717,938.26 |
| Taxes Payable |
1,017,630.94 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,615,498.41 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,535,572.30 |
| Other Current Liabilities |
3,041,757.97 |
| Sub-Total of Current Liabilities |
12,266,205.52 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
119,911.00 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,831,001.86 |
| Total Liabilities |
14,097,207.38 |
| Paid-In Capital(Or Share Stock) |
316,106,775.00 |
| Capital Surplus |
972,065,308.42 |
| Surplus Reserve |
6,988,563.43 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-712,251,756.81 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
582,908,890.04 |
| Owner's Equity（Stockholder's Equity） |
582,908,890.04 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
597,006,097.42 |
